Abeona Therapeutics (ABEO) Accumulated Expenses (2010 - 2026)

Abeona Therapeutics' Accumulated Expenses history runs 15 years deep, the most recent figure standing at $2.6 million for Q1 2026.

• In Q1 2026, Accumulated Expenses fell 32.57% year-over-year to $2.6 million; the TTM figure through Mar 2026 stood at $2.6 million (down 32.57% YoY), while the FY2025 annual figure was $8.5 million, up 33.7% from the prior year.
• Accumulated Expenses for Q1 2026 stood at $2.6 million, down from $8.5 million in the prior quarter.
• The five-year high for Accumulated Expenses was $8.5 million in Q4 2025, with the low at $745000.0 in Q1 2022.
• The 5-year median for Accumulated Expenses is $3.1 million (2025), against an average of $3.7 million.
• The sharpest annual moves came in 2022 and 2024: Accumulated Expenses tumbled 74.02% in 2022, then surged 233.05% in 2024.
• Abeona Therapeutics' Accumulated Expenses stood at $2.6 million in 2022, then jumped by 130.81% to $6.0 million in 2023, then increased by 5.81% to $6.3 million in 2024, then jumped by 33.7% to $8.5 million in 2025, then plunged by 69.04% to $2.6 million in 2026.
• Business Quant data shows ABEO's Accumulated Expenses at $2.6 million in Q1 2026, $8.5 million in Q4 2025, and $6.9 million in Q3 2025.